Search results
Results from the WOW.Com Content Network
The methodology was first invented by Marshall Stoller at UCSF Medical Center, San Francisco, and was first known as the SANS (Stoller Afferent Nerve Stimulator) protocol. In 2000, Stoller reported that 98 patients were treated with the SANS device with an approximate 80% success rate in treating urge incontinence syndrome, including urgency ...
[70] [71] A 2019 review found that this type of therapy may reduce symptoms of CPPS without side effects, but may not improve sexual problems. [64] 5-alpha reductase inhibitors probably help to reduce prostatitis symptoms in men with CPSS and don't appear to cause more side effects than when a placebo is taken. [64]
Benjamin N. Breyer is an American urologic surgeon. As a Professor of Urology, Epidemiology, and Biostatistics at the University of California, San Francisco, he specializes in complex urethral and penile reconstruction, male incontinence, male fistula, surgical treatment for erectile dysfunction.
A 2019 Cochrane review of 59 studies that included 8924 men with urinary symptoms due to benign prostatic hyperplasia. [4] This review found that bipolar and monopolar TURP probably results in comparable improvements in urinary symptoms, as well as a similar erectile function , the incidence of urinary incontinence, and the need for retreatment.
Prostatic artery embolization (PAE, or prostate artery embolisation) is a non-surgical technique for treatment of benign prostatic hyperplasia (BPH). [1]The procedure involves blocking the blood flow of small branches of the prostatic arteries using microparticles injected via a small catheter, [2] to decrease the size of the prostate gland to reduce lower urinary tract symptoms.
The journal was established in 2004 as Nature Clinical Practice Urology and obtained its current title in April 2009. [1] The editor-in-chief is Annette Fenner. [2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 16.430, ranking it 4th out of 90 journals in the category "Urology & Nephrology". [3]
SARMs can be agonists, antagonists, or partial agonists of the AR depending on the tissue, which can enable targeting specific medical conditions while minimizing side effects. [7] Those that have advanced to human trials show stronger effects in bone and muscle tissue and weaker effects in the prostate. [8]
San Francisco opened its first permanent hospital in 1857. [18] A hospital has been at Potrero Avenue since 1872, [19] when the city of San Francisco built a 400-bed hospital on Potrero, an all wood hospital, one of four emergency hospitals eventually built by 1904, Central, Harbor, Park and Potrero. [20]